DY4-24767-58983
3 vaccinations
6 coded responses
20 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 46-50
- ZIP prefix
- 100 / NY
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-09
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-09
Registered in v-safe
- 2021-04-09
- 2021-04-13
- 2021-04-21
- 2021-06-08
- 2021-09-07
-
2021-10-25
Dose 2 — Pfizer-BioNTech
-
2021-11-01
Survey response — day 7, dose 2MedDRA: Headache, Reaction to previous exposure to any vaccine — Feeling: FairFree text: Not today, but within the past 24 hours I had a crunching headache that lasted 8+ hours and was basically the same kind of headache I experienced after getting the J&J in March 2021. Today I'm totally fine though.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-08
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
-
2022-01-24
Survey response — 3 months, dose 2MedDRA: Headache, Respiratory tract congestion — Feeling: Good · Be unable to do your normal daily activitiesFree text: Headache and congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-18
Dose 3 — Moderna
-
2022-04-28
Survey response — 6 months, dose 2MedDRA: Acne — Feeling: FairFree text: Acne outbreak on backMedDRA releases: 2024-11 · check-in free text available
-
2022-05-02
Survey response — day 14, dose 3MedDRA: Fatigue, Headache, Musculoskeletal stiffness — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, stiff neck, fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-05-09
-
2022-05-16
Survey response — day 28, dose 3MedDRA: Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache for ~18 hrs incl overnight, onceMedDRA releases: 2024-11 · check-in free text available
- 2022-05-23
- 2022-05-30
-
2022-07-18
Survey response — 3 months, dose 3MedDRA: Chills, Diarrhoea, Headache, Pain, Patient isolation, Pyrexia — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Aches, chills, 102F, very bad headache. I had a relapse (symptoms resurgence) at day 7 with additional diarrhea. I was triple-vaxxed & double boosted & wore a U.S.-made N95 in public . (5-day isolation is insufficiently short & the CDC knows it.)MedDRA releases: 2024-11 · check-in free text available
-
2022-07-18
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-19
Call successfulParticipant prefers to complete VAERS report online
- 2023-04-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-25 | Pfizer-BioNTech | No |
| 3 | 2022-04-18 | Moderna | No |
Call center
1 call center case
1 successful
Free text
Release 10 — day 7, dose 2
Systemic reaction (other): Not today, but within the past 24 hours I had a crunching headache that lasted 8+ hours and was basically the same kind of headache I experienced after getting the J&J in March 2021. Today I'm totally fine though.
Release 11 — 3 months, dose 2
Symptoms: Headache and congestion.
Release 11 — 6 months, dose 2
Symptoms: Acne outbreak on back
Release 11 — day 14, dose 3
Symptoms: Headache, stiff neck, fatigue
Release 11 — day 28, dose 3
Symptoms: Headache for ~18 hrs incl overnight, once
Release 12 — 3 months, dose 3
Symptoms: Aches, chills, 102F, very bad headache. I had a relapse (symptoms resurgence) at day 7 with additional diarrhea. I was triple-vaxxed & double boosted & wore a U.S.-made N95 in public . (5-day isolation is insufficiently short & the CDC knows it.)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Acne | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Musculoskeletal stiffness | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Reaction to previous exposure to any vaccine | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release